A citation-based method for searching scientific literature

Marc S Rendell. Expert Opin Pharmacother 2018
Times Cited: 5







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Non-systemic drugs: a critical review.
Dominique Charmot. Curr Pharm Des 2012
52
40

Development of SGLT1 and SGLT2 inhibitors.
Timo Rieg, Volker Vallon. Diabetologia 2018
90
40

Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2.
Chiara Ghezzi, Donald D F Loo, Ernest M Wright. Diabetologia 2018
91
40


Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives.
Chiara Maria Assunta Cefalo, Francesca Cinti, Simona Moffa, Flavia Impronta, Gian Pio Sorice, Teresa Mezza, Alfredo Pontecorvi, Andrea Giaccari. Cardiovasc Diabetol 2019
43
40

Comparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview.
Ranjeet Prasad Dash, R Jayachandra Babu, Nuggehally R Srinivas. Xenobiotica 2017
10
40


Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling.
Gary Tresadern, Andres A Trabanco, Laura Pérez-Benito, John P Overington, Herman W T van Vlijmen, Gerard J P van Westen. J Chem Inf Model 2017
13
20


Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data.
Gerard J P van Westen, Olaf O van den Hoven, Rianne van der Pijl, Thea Mulder-Krieger, Henk de Vries, Jörg K Wegner, Adriaan P Ijzerman, Herman W T van Vlijmen, Andreas Bender. J Med Chem 2012
33
20

Phenylglucosides and the Na+/glucose cotransporter (SGLT1): analysis of interactions.
M P Lostao, B A Hirayama, D D Loo, E M Wright. J Membr Biol 1994
79
20

SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice.
Leonardo Spatola, Silvia Finazzi, Claudio Angelini, Marco Dauriz, Salvatore Badalamenti. Diabetes Ther 2018
11
20

LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice.
David R Powell, Melinda G Smith, Deon D Doree, Angela L Harris, Jennifer Greer, Christopher M DaCosta, Andrea Thompson, Sabrina Jeter-Jones, Wendy Xiong, Kenneth G Carson,[...]. J Pharmacol Exp Ther 2017
15
20


Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets.
Gerard Jp van Westen, Remco F Swier, Isidro Cortes-Ciriano, Jörg K Wegner, John P Overington, Adriaan P Ijzerman, Herman Wt van Vlijmen, Andreas Bender. J Cheminform 2013
36
20


Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes.
Christine Clar, James Alexander Gill, Rachel Court, Norman Waugh. BMJ Open 2012
149
20

Sodium-glucose cotransport.
Søren Brandt Poulsen, Robert A Fenton, Timo Rieg. Curr Opin Nephrol Hypertens 2015
62
20

The mechanism of sodium and substrate release from the binding pocket of vSGLT.
Akira Watanabe, Seungho Choe, Vincent Chaptal, John M Rosenberg, Ernest M Wright, Michael Grabe, Jeff Abramson. Nature 2010
136
20

Biology of human sodium glucose transporters.
Ernest M Wright, Donald D F Loo, Bruce A Hirayama. Physiol Rev 2011
721
20

Intestinal SGLT1 in metabolic health and disease.
Anders Lehmann, Pamela J Hornby. Am J Physiol Gastrointest Liver Physiol 2016
29
20

ChEMBL: a large-scale bioactivity database for drug discovery.
Anna Gaulton, Louisa J Bellis, A Patricia Bento, Jon Chambers, Mark Davies, Anne Hersey, Yvonne Light, Shaun McGlinchey, David Michalovich, Bissan Al-Lazikani,[...]. Nucleic Acids Res 2012
20


Inhibitor binding mode and allosteric regulation of Na+-glucose symporters.
Paola Bisignano, Chiara Ghezzi, Hyunil Jo, Nicholas F Polizzi, Thorsten Althoff, Chakrapani Kalyanaraman, Rosmarie Friemann, Matthew P Jacobson, Ernest M Wright, Michael Grabe. Nat Commun 2018
17
20


The ChEMBL bioactivity database: an update.
A Patrícia Bento, Anna Gaulton, Anne Hersey, Louisa J Bellis, Jon Chambers, Mark Davies, Felix A Krüger, Yvonne Light, Lora Mak, Shaun McGlinchey,[...]. Nucleic Acids Res 2014
860
20

The ChEMBL database in 2017.
Anna Gaulton, Anne Hersey, Michał Nowotka, A Patrícia Bento, Jon Chambers, David Mendez, Prudence Mutowo, Francis Atkinson, Louisa J Bellis, Elena Cibrián-Uhalte,[...]. Nucleic Acids Res 2017
781
20

Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus.
B Komoroski, N Vachharajani, Y Feng, L Li, D Kornhauser, M Pfister. Clin Pharmacol Ther 2009
269
20

Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.
Valentin Gorboulev, Annette Schürmann, Volker Vallon, Helmut Kipp, Alexander Jaschke, Dirk Klessen, Alexandra Friedrich, Stephan Scherneck, Timo Rieg, Robyn Cunard,[...]. Diabetes 2012
417
20


Canagliflozin mediated dual inhibition of mitochondrial glutamate dehydrogenase and complex I: an off-target adverse effect.
Philipp F Secker, Sascha Beneke, Nadja Schlichenmaier, Johannes Delp, Simon Gutbier, Marcel Leist, Daniel R Dietrich. Cell Death Dis 2018
28
20

Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes.
Nicole C Goodwin, Zhi-Ming Ding, Bryce A Harrison, Eric D Strobel, Angela L Harris, Melinda Smith, Andrea Y Thompson, Wendy Xiong, Faika Mseeh, Debra J Bruce,[...]. J Med Chem 2017
32
20

SLC transporters as therapeutic targets: emerging opportunities.
Lawrence Lin, Sook Wah Yee, Richard B Kim, Kathleen M Giacomini. Nat Rev Drug Discov 2015
289
20

Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.
Fabian Sievers, Andreas Wilm, David Dineen, Toby J Gibson, Kevin Karplus, Weizhong Li, Rodrigo Lopez, Hamish McWilliam, Michael Remmert, Johannes Söding,[...]. Mol Syst Biol 2011
20

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.
Arthur T Sands, Brian P Zambrowicz, Julio Rosenstock, Pablo Lapuerta, Bruce W Bode, Satish K Garg, John B Buse, Phillip Banks, Rubina Heptulla, Marc Rendell,[...]. Diabetes Care 2015
125
20

QSAR applicabilty domain estimation by projection of the training set descriptor space: a review.
Joanna Jaworska, Nina Nikolova-Jeliazkova, Tom Aldenberg. Altern Lab Anim 2005
295
20

Structure-based identification of OATP1B1/3 inhibitors.
Tom De Bruyn, Gerard J P van Westen, Adriaan P Ijzerman, Bruno Stieger, Peter de Witte, Patrick F Augustijns, Pieter P Annaert. Mol Pharmacol 2013
83
20

Which compound to select in lead optimization? Prospectively validated proteochemometric models guide preclinical development.
Gerard J P van Westen, Jörg K Wegner, Peggy Geluykens, Leen Kwanten, Inge Vereycken, Anik Peeters, Adriaan P Ijzerman, Herman W T van Vlijmen, Andreas Bender. PLoS One 2011
33
20

Activity, assay and target data curation and quality in the ChEMBL database.
George Papadatos, Anna Gaulton, Anne Hersey, John P Overington. J Comput Aided Mol Des 2015
59
20


Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin.
Motoshi Ouchi, Kenzo Oba, Kohei Kaku, Hideki Suganami, Akihiro Yoshida, Yasunori Fukunaka, Promsuk Jutabha, Asuka Morita, Naoyuki Otani, Keitaro Hayashi,[...]. Diabetes Obes Metab 2018
12
20

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials.
Vlado Perkovic, Dick de Zeeuw, Kenneth W Mahaffey, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Terrance D Barrett, Michele Weidner-Wells, Hsiaowei Deng, David R Matthews,[...]. Lancet Diabetes Endocrinol 2018
247
20

C-Glucosides with heteroaryl thiophene as novel sodium-dependent glucose cotransporter 2 inhibitors.
Yuichi Koga, Shigeki Sakamaki, Mitsuya Hongu, Eiji Kawanishi, Toshiaki Sakamoto, Yasuo Yamamoto, Hirotaka Kimata, Keiko Nakayama, Chiaki Kuriyama, Yasuaki Matsushita,[...]. Bioorg Med Chem 2013
12
20



SGLT2 inhibitors for the treatment of diabetes: a patent review (2013-2018).
Jyotsana Pandey, Akhilesh K Tamrakar. Expert Opin Ther Pat 2019
7
20

HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study.
Thomas Danne, Bertrand Cariou, Phillip Banks, Michael Brandle, Helmut Brath, Edward Franek, Jake A Kushner, Pablo Lapuerta, Darren K McGuire, Anne L Peters,[...]. Diabetes Care 2018
82
20

Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor.
Pablo Lapuerta, Brian Zambrowicz, Paul Strumph, Arthur Sands. Diab Vasc Dis Res 2015
69
20

Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways.
Habib Yaribeygi, Alexandra E Butler, Stephen L Atkin, Niki Katsiki, Amirhossein Sahebkar. J Cell Physiol 2018
40
20

Development of a Scalable Synthesis of Tofogliflozin.
Yoshihito Ohtake, Takashi Emura, Masahiro Nishimoto, Koji Takano, Keisuke Yamamoto, Satoshi Tsuchiya, Sang-Yong Yeu, Yasushi Kito, Nobuaki Kimura, Sunao Takeda,[...]. J Org Chem 2016
7
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.